Loading...
XASX
IMR
Market cap419mUSD
Aug 03, Last price  
1.86AUD
1D
0.00%
1Q
-1.06%
IPO
51.22%
Name

Imricor Medical Systems Inc

Chart & performance

D1W1MN
XASX:IMR chart
P/E
P/S
1,381.75
EPS
Div yield, %
Shrs. gr., 5y
22.11%
Rev. gr., 5y
-15.50%
Revenues
303k
-68.47%
703,919565,5971,342,573639,704702,161696,267816,011615,568959,424302,502
Net income
-26m
L-11.76%
-5,494,861-6,710,723-7,297,118-14,798,147-13,076,801-20,556,113-17,534,184-22,625,902-29,692,831-26,201,489
CFO
-20m
L+26.79%
-4,051,414-5,647,803-6,340,013-6,627,993-12,230,689-17,488,546-16,510,221-12,977,456-15,573,910-19,746,569

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
IPO date
Aug 30, 2019
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT